Combination of MEK1/2 Inhibitor and LXR Ligand Synergistically Inhibit Atherosclerosis in LDLR Deficient Mice.
Biochemical and Biophysical Research Communications(2020)
Key words
MEK1/2 inhibitor,LXR ligand,LDLR deficiency mice,Atherosclerosis,Triglyceride
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined